NewGenIvf Group

NewGenIvf Group Financial Leverage

The Financial Leverage (Equity Multiplier) of NewGenIvf Group (NIVF) as of Oct 21, 2026 is 1.23. In the previous year, Financial Leverage (Equity Multiplier) was -3.41 — a change of -136.01% (higher).

Financial Leverage

1.23

YoY

-136.01%

Last updated:

Financial Leverage (Equity Multiplier) of NewGenIvf Group is 2025 1.23 . Financial Leverage (Equity Multiplier) of NewGenIvf Group was 2024 -3.41 . It decreases by -136.01% higher compared to the previous year.

The NewGenIvf Group Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2021
-1.82 USD
Jan 1, 2022
5.16 USD
Jan 1, 2023
1.37 USD
Jan 1, 2024
-3.41 USD
Jan 1, 2025
1.23 USD
The NewGenIvf Group Financial Leverage history
YEARFinancial LeverageYoY
1.23-136.01%
-3.41-349.61%
1.37-73.50%
5.16-383.34%
-1.82—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NewGenIvf Group Stock analysis

What does NewGenIvf Group do? NewGenIvf Group Ltd provides comprehensive fertility services across Asia, including IVF, ICSI, IUI, and MRT techniques. The company operates clinics in Thailand, Cambodia, and Kyrgyzstan, offering treatments such as embryo transfer, chromosome screening, egg freezing, and sperm aspiration. Patients seeking assisted reproductive technology services, including those requiring third-party egg donation or surrogacy, are the primary customers. The firm generates revenue through direct patient fees for these specialized fertility treatments and related services across its Asian clinics. The company's service portfolio includes Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), semen analysis, and sperm extraction procedures. These services are delivered through clinics in Thailand, Cambodia, and Kyrgyzstan, targeting individuals and couples facing infertility challenges. Revenue is derived from the full range of fertility treatments provided at these locations. NewGenIvf Group Ltd's offerings encompass full-spectrum infertility care, including egg and sperm donation programs and surrogacy services within compliant jurisdictions. The clinics serve patients requiring advanced reproductive technologies, with MRT being a specialized service involving third-party egg contribution. The business model relies on direct patient payments for all treatment packages and ancillary services provided at its Asian locations. NewGenIvf Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NewGenIvf Group stock

Financial Leverage (Equity Multiplier) of NewGenIvf Group is 1.23 in 2025.

Financial Leverage (Equity Multiplier) of NewGenIvf Group changed from -3.41 to 1.23, representing a -136.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) NewGenIvf Group since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s NewGenIvf Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — NewGenIvf Group

All Key Metrics — NewGenIvf Group